The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent

TW-37 is a novel, potent and non-peptide Bcl-2 small-molecule inhibitor. Its activity in colorectal cancer (CRC) cells is studied. In both HCT-116 cells and primary human colon cancer cells, treatment with TW-37 at only nM concentration efficiently inhibited cell survival and proliferation. TW-37 al...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Shun, Ding, Yao, Fu, Yun, Wu, Shuang, Xie, Xiong, Wang, Cancan, Liang, Houjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655484/
https://www.ncbi.nlm.nih.gov/pubmed/29065135
http://dx.doi.org/10.1371/journal.pone.0184501